Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

LVRO vs EUDA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EUDA Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–4 Matrix Metrics)

EUDA Overall Winner 6-Pillar Tally: LVRO 2 – 3 EUDA (1 Tie) Matrix Metrics: LVRO 4 – 5 EUDA

As of Nov 20, 2026, EUDA Health Holdings Limited (EUDA) is the stronger overall head-to-head candidate over Lavoro Limited Class A (LVRO) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). LVRO carries a Unified Composite Score of 41.1/100 (SELL) at $0.30 (63.7x Forward P/E, 0.2% operating margin), whereas EUDA carries 38.1/100 (SELL) at $15.96 (10.0x Forward P/E, -28.6% operating margin).

  • Composite vs. Pillar Nuance: While LVRO currently prints a higher short-term Unified Composite Score (41.1/100 SELL vs. EUDA 38.1/100 SELL), EUDA captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-28.6% vs. 0.2% operating margin) and revenue trajectory (+13.4% vs. -13.2% YoY).
  • Defensive Composite Rating Caution: Although EUDA compares more favorably head-to-head, both LVRO (41.1/100 SELL) and EUDA (38.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: LVRO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4); meanwhile EUDA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About LVRO vs EUDA
LVRO NASDAQ
Lavoro Limited Class A Ordinary Shares
Retail-Miscellaneous Retail
$0.30
-24.42% 1D
Market Cap $60.8M
TTM Revenue $9.08B
Forward P/E 63.7x
Beta / 30D Vol 1.04β · 160% Vol
Unified Composite Score
41.1 / 100 SELL
Tech 55.0 Fund 46.0 Flow 50.0 Mom 26.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 21
RSI-14: 21.4 · SMA20: $0.94 · SMA50: $0.89
EUDA NASDAQ Head-to-Head Winner
EUDA Health Holdings Limited Ordinary Shares
Services-Health Services
$15.96
-8.12% 1D
Market Cap $52.0M
TTM Revenue $7.2M
Forward P/E 10.0x
Beta / 30D Vol 12.05β · 113% Vol
Unified Composite Score
38.1 / 100 SELL
Tech 23.0 Fund 33.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.0 · SMA20: $15.42 · SMA50: $16.05

6-Pillar Scorecard Institutional Category Breakdown (LVRO 2 – 3 EUDA)

Columns: Metric · LVRO · EUDA
1. Valuation Multiples EUDA
Forward P/E 63.7x 10.0x
Trailing P/E 63.7x 7.8x
PEG Ratio N/M N/M
EV / Revenue N/M 7.2x
2. Growth & Scale EUDA
Revenue Growth (YoY) -13.2% +13.4%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $9.08B $7.2M
Market Cap $60.8M $52.0M
3. Profitability & Quality LVRO
Gross Margin 15.0% 47.6%
Operating Margin 0.2% -28.6%
Net Profit Margin -10.4% -32.7%
Return on Equity (ROE) -62.4% -211.4%
4. Balance Sheet & Cash Flow LVRO
Cash Generation (TTM) $106M EBITDA -$1.8M EBITDA
Cash Flow Margin 1.2% EBITDA Mgn -25.5% EBITDA Mgn
Net Cash / Leverage $1.35 Book/Sh · -62.4% ROE $2.00 Book/Sh · -211.4% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat EUDA
OpEx & R&D Intensity 14.8% of Rev ($1.34B) 76.2% of Rev ($5.5M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Agricultural Inputs Operator Real Estate Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: LVRO (4) vs EUDA (5)
Institutional Metric LVRO EUDA Criterion Row Edge
Market Capitalization
Scale
$60.8M $52.0M Larger Scale Tie
Trailing P/E Ratio
Valuation
63.7x 7.8x Lower Multiple EUDA
Forward P/E Ratio
Valuation
63.7x 10.0x Lower Multiple EUDA
Revenue Growth (YoY)
Growth
-13.2% +13.4% Higher Growth EUDA
Operating Margin (TTM)
Profitability
0.2% -28.6% Higher Margin LVRO
Net Profit Margin
Profitability
-10.4% -32.7% Higher Margin LVRO
Return on Equity (ROE)
Capital Efficiency
-62.4% -211.4% Higher ROE LVRO
52-Week Range Position
Momentum
2% ($0–$5) 62% ($0–$26) Stronger Trend EUDA
Beta / 30D Volatility
Risk Regime
1.04β · 160% Vol 12.05β · 113% Vol Lower Realized Risk EUDA
Unified Institutional Score
Composite Signal
41.1 / 100 (SELL) 38.1 / 100 (SELL) Higher Composite LVRO
Trailing 12M Revenue (USD)
Operating Scale
$9.08B $7.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
15.0% 47.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 7.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$106M EBITDA ($1.35 Book/Sh · -62.4% ROE) -$1.8M EBITDA ($2.00 Book/Sh · -211.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EUDA +25.95 pp
LVRO: -72.36% · EUDA: -46.41%
3M Horizon EUDA +3.02 pp
LVRO: -73.79% · EUDA: -70.77%
6M Horizon EUDA +2.3 pp
LVRO: -75.08% · EUDA: -72.78%
1Y Horizon EUDA +2.3 pp
LVRO: -75.08% · EUDA: -72.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LVRO vs EUDA. Trailing 12-month operating profitability (LVRO 0.2% vs EUDA -28.6%) and valuation multiples (LVRO 63.7x vs EUDA 10.0x Forward P/E) are benchmarked directly in Pillar 4 below.

LVRO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$9.08B
Gross Margin15.0%
Op. Margin0.2%
ROE / Fwd P/E-62.4% · 63.7x
EUDA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$7.2M
Gross Margin47.6%
Op. Margin-28.6%
ROE / Fwd P/E-211.4% · 10.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
LVRO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LVRO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EUDA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EUDA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
LVRO Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $60.8M market capitalization and 0.2% operating margin.
OpEx & R&D Reinvestment 14.8% of Rev ($1.34B)
90D Engineering Disclosures 0 Published
EUDA Moat Profile Cyclical / Execution-Driven Positioning
Real Estate Services Operator
Competes within the Real Estate Services value chain with $52.0M market capitalization and -28.6% operating margin.
OpEx & R&D Reinvestment 76.2% of Rev ($5.5M)
90D Engineering Disclosures 0 Published

Investor FAQ LVRO vs EUDA Key Questions & Quantitative Answers

As of Nov 20, 2026, EUDA Health Holdings Limited (EUDA) is the stronger overall head-to-head candidate over Lavoro Limited Class A (LVRO) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). LVRO carries a Unified Composite Score of 41.1/100 (SELL) at $0.30 (63.7x Forward P/E, 0.2% operating margin), whereas EUDA carries 38.1/100 (SELL) at $15.96 (10.0x Forward P/E, -28.6% operating margin). Composite vs. Pillar Nuance: While LVRO currently prints a higher short-term Unified Composite Score (41.1/100 SELL vs. EUDA 38.1/100 SELL), EUDA captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-28.6% vs. 0.2% operating margin) and revenue trajectory (+13.4% vs. -13.2% YoY). Defensive Composite Rating Caution: Although EUDA compares more favorably head-to-head, both LVRO (41.1/100 SELL) and EUDA (38.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: LVRO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4); meanwhile EUDA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

EUDA leads the Growth & Scale pillar: LVRO posts -13.2% YoY revenue growth and +0.0% YoY earnings growth on $9.08B TTM revenue (15.0% gross margin, 0.2% operating margin), compared with EUDA at +13.4% YoY revenue growth and +0.0% YoY earnings growth on $7.2M TTM revenue (47.6% gross margin, -28.6% operating margin). On trailing 12-month operating scale, LVRO generates $9.08B in USD-normalized revenue versus $7.2M for EUDA. In operating R&D and SG&A reinvestment, LVRO deploys 14.8% of Rev ($1.34B) (0 90-day corporate R&D disclosures) versus 76.2% of Rev ($5.5M) (0 disclosures) for EUDA.

EUDA screens cheaper on headline valuation multiples. LVRO trades at 63.7x Forward P/E, 63.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (1.2% EBITDA margin), whereas EUDA trades at 10.0x Forward P/E, 7.8x Trailing P/E, N/M PEG, and 7.2x EV/Revenue (-25.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LVRO (-62.4% ROE) versus EUDA (-211.4% ROE) capital efficiency.

In options market volatility and institutional positioning, LVRO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 160% Vol realized risk). By comparison, EUDA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (12.05β · 113% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.